Printer Friendly

DIAGNOSTEK APPOINTS DUKE RODRIGUEZ COO

 ALBUQUERQUE, N.M., Feb. 3 /PRNewswire/ -- Diagnostek, Inc. (NYSE: DXK) today announced that Duke Rodriguez has been named executive vice president and chief operating officer of the company, which is a leader in health care cost containment.
 Mr. Rodriguez most recently served as vice president and chief operating officer of Lovelace, Inc., a wholly-owned subsidiary of CIGNA Corporation and the largest HMO in New Mexico with about 130,000 members. Mr. Rodriguez, 35, joined Lovelace in 1980, and since becoming chief operating officer in 1989, helped build the HMO from a revenue base of approximately $30 million to its current level of approximately $260 million.
 Arthur Solomon, currently executive president and chief operating officer, will now concentrate on his role as president of the company's largest subsidiary, Health Care Services (HCS), engaged in providing pharmacy services to corporations, unions and other benefit sponsors.
 "Duke Rodriguez is an executive of proven talent in managing the rapid growth of a leading health care services company," said Nunzio DeSantis, Diagnostek chairman and chief executive officer. "His expertise and energy will be a vital asset to Diagnostek as we pursue our strategy for continued growth in the health care cost containment field. With the company's rapid expansion and significant opportunities ahead, it is appropriate that the duties of a corporate chief operating officer and the head of our HCS subsidiary be divided. With Mr. Solomon at HCS and Mr. Rodriguez as corporate chief operating officer, we have a strong and deep management team."
 "Diagnostek has a unique combination of pharmacy management and mail order prescription services that give it major strategic advantages in expanding its business," Mr. Rodriguez said. "The company's experienced staff and its state-of-the-art distribution systems position it for growth in a business that will benefit from both demographic trends and the urgency of health care cost containment."
 Prior to joining Lovelace, Mr. Rodriguez served with Touche, Ross and company. He holds a bachelors degree in accounting from New Mexico State University.
 Diagnostek, Inc. is a leading provider of comprehensive pharmacy services designed to contain the costs of dispensing pharmaceuticals. The company dispenses prescription drugs by mail to beneficiaries of health benefit plans and provides contract pharmacy management services to hospitals, managed care providers and other institutions.
 -0- 02/03/93
 /CONTACT: Fredric Spar of Kekst and Company, 212-593-2655, for Diagnostek, Inc./
 (DXK)


CO: Diagnostek, Inc. ST: New Mexico IN: MTC SU: PER

AH -- NY015 -- 2273 02/03/93 09:52 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 3, 1993
Words:410
Previous Article:LCS INDUSTRIES REPORTS SALES AND EARNINGS FOR ITS FIRST QUARTER ENDED DEC. 31, 1992
Next Article:INTEGRATED HEALTH SERVICES PURCHASES AN INTEREST IN THE TUTERA GROUP
Topics:


Related Articles
DIAGNOSTEK RESPONDS TO TRADING ACTIVITY
DIAGNOSTEK NAMES WILLIAM A. BARRON CHIEF FINANCIAL OFFICER
DIAGNOSTEK, INC. SIGNS PRESCRIPTION DRUG AGREEMENT WITH AFLAC
DIAGNOSTEK ANNOUNCES NEW PRESCRIPTION CREDIT CARD PRODUCT SPONSORED WITH THE NATIONAL RURAL ELECTRIC COOPERATIVE ASSOCIATION
DIAGNOSTEK REPORTS $0.15 PER SHARE FOURTH QUARTER NET EARNINGS BEFORE SETTLEMENT CHARGES; TOTAL YEAR REVENUES UP 27% FROM PRIOR YEAR
DIAGNOSTEK'S WILLIAM BARRON ADDS COO TITLE FOLLOWING RESIGNATION OF DUKE RODRIGUEZ
DIAGNOSTEK CONFIRMS CHRYSLER PRESCRIPTION DRUG CONTRACT
DIAGNOSTEK AUTHORIZED TO PROCEED WITH NEW JERSEY CONTRACT
VALUE HEALTH, INC. & DIAGNOSTEK RENEGOTIATE MERGER AGREEMENT
DIAGNOSTEK REPORTS FISCAL YEAR 1995 RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters